Diminished Global Arginine Bioavailability and Increased Arginine Catabolism as Metabolic Profile of Increased Cardiovascular Risk

. Author manuscript; available in PMC: 2010 Jun 2.

Published in final edited form as: J Am Coll Cardiol. 2009 Jun 2;53(22):2061–2067. doi: 10.1016/j.jacc.2009.02.036

Figure 2. Distribution of myocardial infraction/stroke, all-cause mortality, and 3-year incidence of major adverse cardiac events according to global arginine bioavailability ratio (GABR) and arginine quartiles.